What is the BTAI stock price prediction for next 2 weeks?

According to our price prediction algorithm,BioXcel Therapeutics, Inc. (BTAI) price will be around $0.41 in the next 2 weeks. This means it will increase by 123.31863285556781 from the last closing price. This prediction may vary from other time period filters for BTAI stock.

What can be the highest Possible price of BTAI stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BTAI can achieve the highest price of $0.54 which is 198.25717446966203 higher than last closing price. This prediction may vary from other time period filters for BTAI stock.

What can be the lowest Possible price of BTAI stock in next 2 weeks?

As per the forecast and algorithmic analysis, BTAI stock price can be as low as $0.26 which is 45.3395831008758 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for BTAI stock.

Will BTAI stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that BTAI stock will gain123.31863285556781 in the next 2 weeks. This prediction may vary from other time period filters for BTAI stock.

What is BTAI stock last closing price?

Last closing price of BTAI stock was $0.18.

What is BTAI stock price prediction?

BTAI stock price prediction means predicting the future closing prices of BTAI stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BTAI stock in a certain time period.

How we predict BTAI stock future prices?

If you are searching for BTAI stock forecast, analysis or price prediction, then you might be wondering what BioXcel Therapeutics, Inc. (BTAI) will do in the future. Our BTAI price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BTAI price prediction will likely answer most of your questions.

How frequent we update BTAI stock predictions?

We are updating the forecasts for the BTAI stock on daily basis.

Is using ML forecasting for BTAI stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BTAI stock same for all the time periods?

No, the prediction for BTAI stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

BioXcel Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.18-84.76%Since 2 Weeks

Predicted Price$0.41123.32%For 2 Weeks

Upper Predicted Price$0.54198.26%For 2 Weeks

Lower Predicted Price$0.2645.34%For 2 Weeks

Forecast Score Based on 2 Weeks

100

Based on our forecast, the price of BTAI will rise by +123.32% over the next 2 Weeks and hit $0.41 by Friday, September 11, 2026. In that time frame, BTAI's share price is expected to range between $0.26 and $0.54.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 11, 2026	0.04	0.16	0.28
Sep 10, 2026	0.00	0.12	0.23
Sep 9, 2026	0.01	0.13	0.26
Sep 8, 2026	0.00	0.13	0.25
Sep 7, 2026	0.00	0.12	0.24
Sep 4, 2026	0.05	0.17	0.30
Sep 3, 2026	0.01	0.13	0.25
Sep 2, 2026	0.03	0.14	0.26
Sep 1, 2026	0.02	0.14	0.25
Aug 31, 2026	0.01	0.13	0.26

BTAI shares fell -74.76% in Friday, August 28, 2026's trading session, dropping from a previous close of $0.72 to move at $0.18. The stock demonstrated notable intraday movement (see BTAI's key stats for a full breakdown), fluctuating between $0.16 and $0.22, a +42.77% trading range. While recent weeks have seen some volatility, BTAI has managed to secure a -79.62% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 57.82M shares changing hands, 56.76M more than the previous session. This amounted to $10.49M in total market activity.

Will BTAI Continue Its Upward Trend?

According to analyst ratings and projections for BTAI, BioXcel Therapeutics, Inc. shares are anticipated to increase by +34.67%, potentially reaching $0.28 per share by September 11, 2026. Short-term technical indicators currently suggest a bullish sentiment for BTAI. However, the stock has recorded 16 negative trading days within the past 30 sessions. Based on the BTAI stock forecast, now is a good time to buy BTAI stock because its current trading price is +15.32% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BTAI covering social and institutional perspectives.

BTAI Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BTAI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 15.72% to 26.16%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 35.74%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 41.38%, maintains a neutral outlook for the long term. Insights into BTAI's shareholder base show how institutional investors are positioning themselves during these momentum shifts

BioXcel Therapeutics Short-Term Forecasts

BTAI Forecast For Next 5 Days

Our algorithm anticipates BioXcel Therapeutics (BTAI) stock could hit $0.10 by Sep 04, 2026. This represents a -44.05% fall from today's price, following a -6.44% change over the past five days.

BTAI Forecast For Next 30 Days

Based on analysis of market trends, the outlook for BioXcel Therapeutics, Inc. (BTAI) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.11, which would mean a -39.36% decrease from the current price of $0.18. Projections for this period range from a high of $0.44 to a low of $0.00.

BTAI Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for BioXcel Therapeutics's price over the next three months point to a drop. BTAI stock is expected to peak at $2.99 on Sep 29, 2026 before potentially dipping to $0.00 on Nov 30, 2026. On average, BTAI is likely to trade around $0.03 in the coming 90 days.

BioXcel Therapeutics Stock Forecast 2025

Based on our predictive models, BioXcel Therapeutics (BTAI) is expected to trade between $0.00 and $2.99 throughout 2026. This would result in an average price of $0.03, potentially offering investors a -83.46% return from current levels.

BioXcel Therapeutics, Inc. Monthly Forecast 2026–2027

August 2026

According to our latest forecast models, BioXcel Therapeutics, Inc. (BTAI) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $2.21, settling at an average of $0.03. This could translate to a -83.46% loss.

September 2026

Based on current market signals, BioXcel Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $0.00 to $2.99, with a likely average price of $0.02. Investors could expect a potential return of -88.97%.

October 2026

Our predictive algorithms indicate BioXcel Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$2.78, with an average target of $0.03. This represents a cautious outlook and a possible loss of -83.46%.

November 2026

Analyzing established trends, BioXcel Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $2.78, averaging around $0.03. This suggests a -83.46% loss from current levels.

December 2026

Market indicators suggest BioXcel Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $2.85, with a midpoint forecast of $0.02. The stock might deliver a -88.97% loss.

January 2027

Forecasting for January 2027, models estimate that BioXcel Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.04, averaging $0.03. This signals a cautious trajectory with potential returns around -83.46%.

February 2027

According to our latest forecast models, BioXcel Therapeutics, Inc. (BTAI) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $2.74, settling at an average of $0.02. This could translate to a -88.97% loss.

March 2027

Based on current market signals, BioXcel Therapeutics, Inc. is projected to trend march 2027. We forecast a trading range from $0.00 to $2.95, with a likely average price of $0.02. Investors could expect a potential return of -88.97%.

April 2027

Our predictive algorithms indicate BioXcel Therapeutics, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$2.92, with an average target of $0.01. This represents a cautious outlook and a possible loss of -94.49%.

May 2027

Analyzing established trends, BioXcel Therapeutics, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $2.67, averaging around $0.01. This suggests a -94.49% loss from current levels.

June 2027

Market indicators suggest BioXcel Therapeutics, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $2.82, with a midpoint forecast of $0.01. The stock might deliver a -94.49% loss.

July 2027

Forecasting for July 2027, models estimate that BioXcel Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.82, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.

August 2027

According to our latest forecast models, BioXcel Therapeutics, Inc. (BTAI) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $2.73, settling at an average of $0.00. This could translate to a -100.00% loss.

BTAI's history of dividends and stock splits also plays a role in long-term investor confidence.